Ames concordance with the in vivo transgenic rodent (TGR) gene mutation assay for NDSRIs and relative in vivo TGR potency with nitrosamines with robust dose-response carcinogenicity data.

Jolly RA, Trejo-Martin A, Bercu JP, Powley MW, Tennant RE, Ponting DJ, Nudelman R, Sobol Z, Czich A, Johnson GE, Yang Y, Kobets T, White PA, Minocherhomji S, Lynch AM, Zeller A, Ott GR, Escobar PA, Hobbs C, Schuler M, Chen CL, Puglisi R.

Open source

DOI: 10.1016/j.yrtph.2026.106051
Published: 2026-01-30
Container: Regul Toxicol Pharmacol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.yrtph.2026.106051,
  title = {Ames concordance with the in vivo transgenic rodent (TGR) gene mutation assay for NDSRIs and relative in vivo TGR potency with nitrosamines with robust dose-response carcinogenicity data.},
  author = {Jolly RA and  Trejo-Martin A and  Bercu JP and  Powley MW and  Tennant RE and  Ponting DJ and  Nudelman R and  Sobol Z and  Czich A and  Johnson GE and  Yang Y and  Kobets T and  White PA and  Minocherhomji S and  Lynch AM and  Zeller A and  Ott GR and  Escobar PA and  Hobbs C and  Schuler M and  Chen CL and  Puglisi R.},
  year = {2026},
  journal = {Regul Toxicol Pharmacol},
  doi = {10.1016/j.yrtph.2026.106051},
  url = {https://doi.org/10.1016/j.yrtph.2026.106051}
}

RIS

TY  - JOUR
TI  - Ames concordance with the in vivo transgenic rodent (TGR) gene mutation assay for NDSRIs and relative in vivo TGR potency with nitrosamines with robust dose-response carcinogenicity data.
AU  - Jolly RA
AU  -  Trejo-Martin A
AU  -  Bercu JP
AU  -  Powley MW
AU  -  Tennant RE
AU  -  Ponting DJ
AU  -  Nudelman R
AU  -  Sobol Z
AU  -  Czich A
AU  -  Johnson GE
AU  -  Yang Y
AU  -  Kobets T
AU  -  White PA
AU  -  Minocherhomji S
AU  -  Lynch AM
AU  -  Zeller A
AU  -  Ott GR
AU  -  Escobar PA
AU  -  Hobbs C
AU  -  Schuler M
AU  -  Chen CL
AU  -  Puglisi R.
PY  - 2026
JO  - Regul Toxicol Pharmacol
DO  - 10.1016/j.yrtph.2026.106051
UR  - https://doi.org/10.1016/j.yrtph.2026.106051
ER  -

APA

RA, J., A, T., JP, B., MW, P., RE, T., DJ, P., R, N., Z, S., A, C., GE, J., Y, Y., T, K., PA, W., S, M., AM, L., A, Z., GR, O., PA, E., C, H., M, S., CL, C., & R., P. (2026). Ames concordance with the in vivo transgenic rodent (TGR) gene mutation assay for NDSRIs and relative in vivo TGR potency with nitrosamines with robust dose-response carcinogenicity data.. Regul Toxicol Pharmacol. https://doi.org/10.1016/j.yrtph.2026.106051

Source records

europe-pmc · retrieved 2026-09-27T04:04:28.387Z